CXCL5 and autoimmune disease: Therefore, we focused on CXCR1, the first chemokine receptor cloned in 1991, and its mouse ligand CXCL5/LIX, which has been shown to mediate cell migration and granule release in neutrophils in response to bacterial infections and autoimmune diseases [27, 28].